Concepedia

Rhiannon Coulson

RC

10

Publications

731

Citations

10

H-Index

2014

Active since

Affiliations

Garvan Institute of Medical Research(Current)

St Vincent's Clinic

The University of Melbourne

UNSW Sydney

Peter MacCallum Cancer Centre

Rhiannon Coulson is an author at Garvan Institute of Medical Research specializing in tumor biology, breast cancer, and medicine.

ORCID

Top concepts

Publications per year

2014–2024

10

Publications

10

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

Shawn F. Johnson, Cristina Cruz, Ann Katrin Greifenberg et al. · Cell Reports · 2016 · 279 citations · Full text

CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity

April C. Watt, Paloma Cejas, Molly J. DeCristo et al. · Nature Cancer · 2020 · 107 citations · Full text

, , +11

INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors

Catherine Dietrich, Alec Trub, Antonio Ahn et al. · Cancer Discovery · 2023 · 97 citations · Full text

The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma

Rhiannon Coulson, Seng H. Liew, Angela A. Connelly et al. · Oncotarget · 2017 · 93 citations · Full text

, , +18

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer

Neil Portman, Heloisa Milioli, Sarah Alexandrou et al. · Breast Cancer Research · 2020 · 62 citations · Full text

Rows per page

1–5 of 10